Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00853684
What this trial is testing

Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Shanghai Jiao Tong University School of Medicine 44
Testing effectiveness (Phase 2)UnknownNCT04764006
What this trial is testing

Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study

Who this might be right for
Advanced Colorectal Cancer
Fujian Cancer Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00655499
What this trial is testing

Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 65
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Large-scale testing (Phase 3)Looking for participantsNCT06791512
What this trial is testing

MFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Who this might be right for
Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang 166
Testing effectiveness (Phase 2)WithdrawnNCT06575725
What this trial is testing

Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer

Who this might be right for
Advanced Colon AdenocarcinomaAdvanced Colorectal AdenocarcinomaAdvanced Rectal Adenocarcinoma+9 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543848
What this trial is testing

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Adenocarcinoma
Chongqing University Cancer Hospital 20
Not applicableUnknownNCT03619668
What this trial is testing

Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment

Who this might be right for
Rectal CancerRectal AdenocarcinomaLocally Advanced Malignant Neoplasm
Aalborg University Hospital 16
Not applicableUnknownNCT05877573
What this trial is testing

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer

Who this might be right for
Locally AdvancedHigh-RiskRectal Cancer+1 more
Nanfang Hospital, Southern Medical University 53
Testing effectiveness (Phase 2)UnknownNCT00154713
What this trial is testing

Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 37
Large-scale testing (Phase 3)UnknownNCT02882269
What this trial is testing

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
The First Affiliated Hospital with Nanjing Medical University 400
Testing effectiveness (Phase 2)Looking for participantsNCT06558773
What this trial is testing

GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.

Who this might be right for
Colorectal Cancer
Chinese PLA General Hospital 120
Early research (Phase 1)UnknownNCT00010270
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University Hospital Freiburg 50
Testing effectiveness (Phase 2)Study completedNCT00077337
What this trial is testing

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Looking for participantsNCT07372300
What this trial is testing

Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Carcinoma
Shih-Kai Hung 126
Early research (Phase 1)Study completedNCT05415475
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophageal CancerStomach Cancer+3 more
Chongqing Precision Biotech Co., Ltd 30
Testing effectiveness (Phase 2)Ended earlyNCT01550510
What this trial is testing

Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Who this might be right for
Stage IV Colorectal Cancer
Thomas Jefferson University 4
Testing effectiveness (Phase 2)Study completedNCT00030797
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05969847
What this trial is testing

Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer

Who this might be right for
Rectal Cancer
池畔 72
Testing effectiveness (Phase 2)Study completedNCT00063427
What this trial is testing

Study Evaluating MAC-321 in Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 45
Next Page